# ClinicalTrials.gov record NCT02217800

> PeptideScanner retained ClinicalTrials.gov record NCT02217800 at 2026-07-30T21:12:47.415Z. Its registry update date was 2018-02-15, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct02217800-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-02-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02217800-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02217800-octreotide-v1.json
- Content SHA-256: `bc7077165312f87e2e263853b22aeccee439aa11584d562f400b54599eb0b2b9`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02217800 ([`ctg-observation-nct02217800-2018-02-15-a15b35ad79fa`](#source-ctg-observation-nct02217800-2018-02-15-a15b35ad79fa))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02217800 at 2026-07-30T21:12:47.415Z. Its registry update date was 2018-02-15, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02217800-2018-02-15-a15b35ad79fa`](#source-ctg-observation-nct02217800-2018-02-15-a15b35ad79fa))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02217800 at 2026-07-30T21:12:47.415Z. Its registry update date was 2018-02-15, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02217800-2018-02-15-a15b35ad79fa`](#source-ctg-observation-nct02217800-2018-02-15-a15b35ad79fa))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02217800-2018-02-15-a15b35ad79fa`](#source-ctg-observation-nct02217800-2018-02-15-a15b35ad79fa))

## Sources

<a id="source-ctg-observation-nct02217800-2018-02-15-a15b35ad79fa"></a>
- **ClinicalTrials.gov record NCT02217800 · retained source version 2018-02-15:a15b35ad79fa40328960d80428ce0a614501bbb60d3fec950f9f60b45a42d474** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02217800) (`ctg-observation-nct02217800-2018-02-15-a15b35ad79fa`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02217800." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02217800-octreotide-v1.json SHA-256: bc7077165312f87e2e263853b22aeccee439aa11584d562f400b54599eb0b2b9.